FDA Drug Recalls

Recalls / Class I

Class ID-0248-2022

Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.

Product

LOTRIMIN AF, (Miconazole nitrate 2%), Powder Spray, NET WT 133g (4.6 OZ) can, Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, NDC 11523-0544-2 UPC 3 11017 41025 7

Affected lot / code info
Lot # CV01AP2, EXP 2/28/2022; TN006TD, EXP 3/31/2023; TN008CV, EXP 4/30/2023; TN008CW, EXP 5/31/2023;

Why it was recalled

Chemical Contamination: presence of benzene

Recalling firm

Firm
Bayer Healthcare Pharmaceuticals Inc.
Notification channel
Press Release
Type
Voluntary: Firm initiated
Address
100 Bayer Blvd, N/A, Whippany, New Jersey 07981-1544

Distribution

Quantity
3,816,468 cans
Distribution pattern
Distributed Nationwide in the US, Puerto Rico, Canada and Mexico through a variety of retail channels.

Timeline

Recall initiated
2021-10-01
FDA classified
2021-11-18
Posted by FDA
2021-11-24
Terminated
2023-06-26
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0248-2022. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class I recall: drug · FDA Drug Recalls